Literature DB >> 15122438

[Analysis of methylphenidate's efficacy using the abbreviated version Conners' questionnaire in attention deficit hyperactivity disorder].

Enio Roberto de Andrade1, Claudia Scheuer.   

Abstract

UNLABELLED: The attention deficit/hyperactivity disorder (ADHD) is a complex diagnosis. Its installation is precocious, with chronic evolution that impacts on the subject's performance in several contexts. Three to 5% of the school aged children present this disorder. The Conners' questionnaire has been used as an instrument of epidemiological survey for ADHD children.
OBJECTIVE: This study aimed to investigate if this instrument could be an useful tool for the analysis of the methylphenidate's treatment efficacy in ADHD's children.
METHOD: Twenty-one male children were selected, with ADHD combined type, chronological ages ranging from seven to 10 years and 11 months and all were treated with methylphenidate. The Conners' questionnaire abbreviated version for parents and teachers was applied in two moments, one without medication and another between six to eight months after the beginning of the methylphenidate.
RESULTS: Results pointed to a reduction in punctuation in Conners' questionnaire in all children with ADHD concomitant to clinical improvement.
CONCLUSION: Conners' questionnaire revealed to be useful not only for diagnosis, but also as an instrument to evaluate the effectiveness of the treatment of ADHD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122438     DOI: 10.1590/s0004-282x2004000100014

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  1 in total

1.  Comparison of child self-reports and parent proxy-reports on quality of life of children with attention deficit hyperactivity disorder.

Authors:  Juliana C B Marques; Jorge A Oliveira; Juliana B Goulardins; Roseane O Nascimento; Allana M V Lima; Erasmo B Casella
Journal:  Health Qual Life Outcomes       Date:  2013-11-04       Impact factor: 3.186

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.